Mode
Text Size
Log in / Sign up
N/A N=22 Randomized Treatment

Intraosseous Access in the Emergency Department for Patients With Failed Attempts at Intravenous Access: A Randomized Trial Examining Resource Utilization and Patient Satisfaction

Difficult Peripheral IV Access

Enrolled (actual)
22
Serious AEs
0.0%
Results posted
Mar 2022
Primary outcome: Primary: Time to Successful Placement of a Functioning USGIV/IO — 163.7; 67.3 seconds

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
IO access using EZ-IO® (Procedure)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
WellSpan Health
Primary completion
May 2015

Outcome Measures

OutcomeResultp-value
PRIMARY
Time to Successful Placement of a Functioning USGIV/IO
163.7; 67.3
PRIMARY
Number of Successful Placements
11; 8

Summary

By doing this study, the investigators hope to learn whether patients with difficult to obtain IV access who are treated with IO access are more satisfied with their care and have better outcomes. The investigators are specifically studying the time difference between groups and the difference in the number of attempts required to obtain vascular access and begin to treat with fluids and medications. The study will also measure patient satisfaction and procedural pain, the frequency of central line placement, the length of stay in the hospital and emergency department, and adverse events to intravascular access to determine whether IO access can improve these measures. The investigators hypothesize that the use of a protocol utilizing an IO device for select patients with failed IV access will reduce the time requirements to obtain vascular access, reduce the number of attempts needed to obtain IV access, reduce the ED LOS, and have no negative impact on patient satisfaction compared to the current ED practices.

Eligibility Criteria

Inclusion Criteria

  • 18 years of age or older
  • Hemodynamically stable
  • Speaks English
  • Able to consent
  • Has difficult IV access

Exclusion Criteria

  • Patients who are younger than 18 years of age, b) lack English fluency c) are unable to give informed consent d) require immediate central venous access e) have a history of osteomyelitis in the only target location of IO access f) have a fracture in the bone of the only target IO site g) have received an IO in the last 24 hours of the only target site h) are allergic to lidocaine i) pregnant or j) require a contrast CT scan as part of their ED care will be excluded.

While pregnant patients may benefit from rescue access the use of lidocaine to anesthetize the medullary space has not been studied in this population.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01676350). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search